252 related articles for article (PubMed ID: 19227011)
41. A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies.
Kennedy LC; Bickford LR; Lewinski NA; Coughlin AJ; Hu Y; Day ES; West JL; Drezek RA
Small; 2011 Jan; 7(2):169-83. PubMed ID: 21213377
[TBL] [Abstract][Full Text] [Related]
42. Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells.
Li X; Luwor R; Lu Y; Liang K; Fan Z
Oncogene; 2006 Jan; 25(4):525-35. PubMed ID: 16170346
[TBL] [Abstract][Full Text] [Related]
43. Stability of antibody-conjugated gold nanoparticles in the endolysosomal nanoenvironment: implications for noninvasive radiofrequency-based cancer therapy.
Raoof M; Corr SJ; Kaluarachchi WD; Massey KL; Briggs K; Zhu C; Cheney MA; Wilson LJ; Curley SA
Nanomedicine; 2012 Oct; 8(7):1096-105. PubMed ID: 22349096
[TBL] [Abstract][Full Text] [Related]
44. Biological characterization of cetuximab-conjugated gold nanoparticles in a tumor animal model.
Kao HW; Lin YY; Chen CC; Chi KH; Tien DC; Hsia CC; Lin WJ; Chen FD; Lin MH; Wang HE
Nanotechnology; 2014 Jul; 25(29):295102. PubMed ID: 24990295
[TBL] [Abstract][Full Text] [Related]
45. Targeted cancer therapy by immunoconjugated gold-gold sulfide nanoparticles using Protein G as a cofactor.
Sun X; Zhang G; Patel D; Stephens D; Gobin AM
Ann Biomed Eng; 2012 Oct; 40(10):2131-9. PubMed ID: 22532323
[TBL] [Abstract][Full Text] [Related]
46. The physicochemical and biological characterization of a 24-month-stored nanocomplex based on gold nanoparticles conjugated with cetuximab demonstrated long-term stability, EGFR affinity and cancer cell death due to apoptosis.
Andrade LM; Martins EMN; Versiani AF; Reis DS; da Fonseca FG; Souza IP; Paniago RM; Pereira-Maia E; Ladeira LO
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110203. PubMed ID: 31761220
[TBL] [Abstract][Full Text] [Related]
47. A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer.
Ashton JR; Gottlin EB; Patz EF; West JL; Badea CT
PLoS One; 2018; 13(11):e0206950. PubMed ID: 30408128
[TBL] [Abstract][Full Text] [Related]
48. Effect of Cetuximab-Conjugated Gold Nanoparticles on the Cytotoxicity and Phenotypic Evolution of Colorectal Cancer Cells.
El Hallal R; Lyu N; Wang Y
Molecules; 2021 Jan; 26(3):. PubMed ID: 33499047
[TBL] [Abstract][Full Text] [Related]
49. Enhancing the efficiency of bortezomib conjugated to pegylated gold nanoparticles: an in vitro study on human pancreatic cancer cells and adenocarcinoma human lung alveolar basal epithelial cells.
Coelho SC; Almeida GM; Santos-Silva F; Pereira MC; Coelho MA
Expert Opin Drug Deliv; 2016 Aug; 13(8):1075-81. PubMed ID: 27087021
[TBL] [Abstract][Full Text] [Related]
50. Comparative Effect Between Laser and Radiofrequency Heating of RGD-Gold Nanospheres on MCF7 Cell Viability.
Sánchez-Hernández L; Ferro-Flores G; Jiménez-Mancilla NP; Luna-Gutiérrez MA; Santos-Cuevas CL; Ocampo-García BE; Azorín-Vega E; Isaac-Olivé K
J Nanosci Nanotechnol; 2015 Dec; 15(12):9840-8. PubMed ID: 26682422
[TBL] [Abstract][Full Text] [Related]
51. Cetuximab-conjugated magneto-fluorescent silica nanoparticles for in vivo colon cancer targeting and imaging.
Cho YS; Yoon TJ; Jang ES; Soo Hong K; Young Lee S; Ran Kim O; Park C; Kim YJ; Yi GC; Chang K
Cancer Lett; 2010 Dec; 299(1):63-71. PubMed ID: 20826046
[TBL] [Abstract][Full Text] [Related]
52. Gold nanoparticle-based sensors activated by external radio frequency fields.
Vedova PD; Ilieva M; Zhurbenko V; Mateiu R; Faralli A; Dufva M; Hansen O
Small; 2015 Jan; 11(2):248-56. PubMed ID: 25180655
[TBL] [Abstract][Full Text] [Related]
53. Investigation of the heating properties of platinum nanoparticles under a radiofrequency current.
San BH; Moh SH; Kim KK
Int J Hyperthermia; 2013; 29(2):99-105. PubMed ID: 23350813
[TBL] [Abstract][Full Text] [Related]
54. Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment.
Kumar A; Huo S; Zhang X; Liu J; Tan A; Li S; Jin S; Xue X; Zhao Y; Ji T; Han L; Liu H; Zhang X; Zhang J; Zou G; Wang T; Tang S; Liang XJ
ACS Nano; 2014 May; 8(5):4205-20. PubMed ID: 24730557
[TBL] [Abstract][Full Text] [Related]
55. Gold nanoparticles: emerging paradigm for targeted drug delivery system.
Kumar A; Zhang X; Liang XJ
Biotechnol Adv; 2013; 31(5):593-606. PubMed ID: 23111203
[TBL] [Abstract][Full Text] [Related]
56. Green synthesis of pullulan stabilized gold nanoparticles for cancer targeted drug delivery.
Ganeshkumar M; Ponrasu T; Raja MD; Subamekala MK; Suguna L
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Sep; 130():64-71. PubMed ID: 24762575
[TBL] [Abstract][Full Text] [Related]
57. Antibody-functionalized gold nanoparticles as tumor-targeting radiosensitizers for proton therapy.
Li S; Bouchy S; Penninckx S; Marega R; Fichera O; Gallez B; Feron O; Martinive P; Heuskin AC; Michiels C; Lucas S
Nanomedicine (Lond); 2019 Feb; 14(3):317-333. PubMed ID: 30675822
[TBL] [Abstract][Full Text] [Related]
58. A radio-frequency coupling network for heating of citrate-coated gold nanoparticles for cancer therapy: design and analysis.
Kruse DE; Stephens DN; Lindfors HA; Ingham ES; Paoli EE; Ferrara KW
IEEE Trans Biomed Eng; 2011 Jul; 58(7):2002-12. PubMed ID: 21402506
[TBL] [Abstract][Full Text] [Related]
59. The study on the preparation and characterization of gene-loaded immunomagnetic albumin nanospheres and their anti-cell proliferative effect combined with magnetic fluid hyperthermia on GLC-82 cells.
Zhang H; Hou X; Lin M; Wang L; Li H; Yuan C; Liang C; Zhang J; Zhang D
Drug Des Devel Ther; 2015; 9():6445-60. PubMed ID: 26719671
[TBL] [Abstract][Full Text] [Related]
60. Gold nanoparticles affect the antioxidant status in selected normal human cells.
Daems N; Penninckx S; Nelissen I; Van Hoecke K; Cardinaels T; Baatout S; Michiels C; Lucas S; Aerts A
Int J Nanomedicine; 2019; 14():4991-5015. PubMed ID: 31371943
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
